{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2016"],"condition":["colorectal cancer"],"disease":["Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2637344"],"location":["Japan"],"study_start_month":["4"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"A phase I study of combination immunotherapy with five peptides cocktail, CpG, and immune modulators for patients with advanced or metastatic colorectal cancer","description":"Interventions: combination immunotherapy\nPrimary outcome(s): safety\nStudy Design: Single arm Non-randomized","dates":{"creation":"2016-04-15"},"accession":"2637344","cross_references":{"Japan Primary Registries Network":["JPRN-UMIN000022082"]}}